Similar sites
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#joomla related articles
#joomla admin url
Category
N/AGlobal Rank
N/ARank in 1 month
89.3KEstimate Value
N/ASorry. Description is not currently available
#президенты сша
#продолжительность жизни в россии
#навигация
#поиск
#россия
#справочник
#инструменты
#россии
#мифы
Malware Scan Info
Macafee Check :
Email address with ruxience.com
Recent Searched Sites
Freemix.com (13 seconds ago) / US
Matematika.ilmuhitung.com (16 seconds ago) / US
Praktik-rambla-hotel-barcelona.hotelmix.it (1 mins ago) / US
Colleyvilleflowers.com (11 seconds ago) / US
St-pancras-renaissance-hotel-london.ibooked.ca (1 mins ago) / US
Nunuyy.com (10 seconds ago) / US
Cimaplaza.com (2 mins ago) / US
Ruxience.com (1 seconds ago) / US
Easystreettravel.com (27 seconds ago) / US
Laren.miljoenhuizen.nl (4 mins ago) / US
Immersivecare.com.s3-website-us-west-2.amazonaws.com (41 seconds ago) / US
Parmiss.net (41 seconds ago) / NL
Emfacademy.com (15 seconds ago) / US
Smojs.com (29 seconds ago) / US
Bartholomewhistory.org (37 seconds ago) / US
Emporio-reforma-hotel-mexico-city.booked.net (9 seconds ago) / US
Dndinteng.com (39 seconds ago) / US
Cc5912.com (3 mins ago) / US
Fmc2.fmc.gov (55 seconds ago) / US
Pension-casa-humor-gura-humorului.hotelmix.ro (3 mins ago) / US
Domain Informations
Ruxience.com lookup results from whois.comlaude.com server:
- Domain created: 2015-09-01T17:01:45Z
- Domain updated: 2023-06-02T16:48:16Z
- Domain expires: 2024-09-01T17:01:45Z 0 Years, 78 Days left
- Website age: 8 Years, 287 Days
- Registrar Domain ID: 1956763549_DOMAIN_COM-VRSN
- Registrar Url: http://www.comlaude.com
- Registrar WHOIS Server: whois.comlaude.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +442074218250
- Name server:
- NS1.P201.DNS.ORACLECLOUD.NET
- NS2.P201.DNS.ORACLECLOUD.NET
- NS3.P201.DNS.ORACLECLOUD.NET
- NS4.P201.DNS.ORACLECLOUD.NET
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2021-07-01
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 680399 |
namecheap.com | 224489 |
networksolutions.com | 166122 |
tucows.com | 137881 |
publicdomainregistry.com | 88119 |
whois.godaddy.com | 62267 |
enomdomains.com | 58221 |
cloudflare.com | 49364 |
namesilo.com | 48894 |
gmo.jp | 46192 |
register.com | 39024 |
fastdomain.com | 38301 |
ionos.com | 33869 |
name.com | 32288 |
wildwestdomains.com | 32212 |
net.cn | 31018 |
registrar.amazon.com | 30344 |
dynadot.com | 27920 |
key-systems.net | 27185 |
Host Informations
Host name | 104.18.32.144 |
IP address | 104.18.32.144 |
Location | United States |
Latitude | 37.751 |
Longitude | -97.822 |
Timezone | America/Chicago |
Port Scanner (IP: 104.18.32.144)
Spam Check (IP: 104.18.32.144) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with ruxience.com on Search Engine
Official Patient Website | RUXIENCE® (rituximab-pvvr)
Tell your healthcare provider or get medical help right away if you get any of these symptoms during or after an infusion of RUXIENCE: Hives (red itchy welts) or rash. Itching. Swelling of your lips, tongue, throat, or face. Sudden cough. Shortness of …
Ruxience.comDA: 16 PA: 16 MOZ Rank: 17
Patient Resources | RUXIENCE® (rituximab-pvvr) | Safety …
Patients prescribed RUXIENCE for pemphigus vulgaris are not eligible for this co-pay savings program. With this program, eligible patients may pay as little as $0 co-pay per RUXIENCE treatment, subject to a maximum benefit of $25,000 per calendar year for out-of-pocket expenses for RUXIENCE including co-pays or coinsurances.
Ruxience.comDA: 16 PA: 18 MOZ Rank: 35
Ruxience - Home
Welcome to Ruxience® This site is a source of information on PfizerFlexTM Patient Support Program for patients taking Ruxience®. The PfizerFlexTM Patient Support Program is there to support you at every step of your treatment journey. It will provide you with helpful services including: • A dedicated program coordinator • Reimbursement navigation and financial …
Ruxience.caDA: 15 PA: 9 MOZ Rank: 26
Home Page | RUXIENCE® (rituximab-pvvr) HCP Website | Safety Info
Patients prescribed RUXIENCE for pemphigus vulgaris are not eligible for this co-pay savings program. With this program, eligible patients may pay as little as $0 co-pay per RUXIENCE treatment, subject to a maximum benefit of $25,000 per calendar year for out-of-pocket expenses for RUXIENCE including co-pays or coinsurances.
Ruxience.pfizerpro.comDA: 22 PA: 22 MOZ Rank: 26
[Product Monograph Template - Standard] - Pfizer Canada
RUXIENCE (rituximab for injection)is a recombinant chimericIgG1 kappa monoclonal antibody (mAb) with two identical heavy (H)chains and two identical light (L) chains, covalently linked with four inter-chain disulfidebonds. RUXIENCE is a CD20-directed cytolytic antibody that is produced by a mammalian cell (Chinese Hamster Ovary [CHO])suspension culture. 8 WARNINGS AND …
Pfizer.caDA: 13 PA: 50 MOZ Rank: 80
FDA Approves Pfizer’s Biosimilar, RUXIENCE™ (rituximab-pvvr), for ...
About RUXIENCE (rituximab-pvvr) RUXIENCE is a mAb biosimilar to Rituxan which works by targeting a protein called CD20, which is present on the surface of B cells. When it attaches to CD20, rituximab helps destroy the B cells. 2. RUXIENCEIMPORTANT SAFETY INFORMATION AND INDICATIONS. BOXED WARNINGS
Pfizer.comDA: 14 PA: 50 MOZ Rank: 45
HIGHLIGHTS OF PRESCRIBING INFORMATION - Pfizer
RUXIENCE (rituximab-pvvr) injection is a sterile, preservative-free, clear to slightly opalescent, colorless to pale brownish-yellow solution for intravenous infusion. RUXIENCE is supplied at a concentration of 10 mg/mL in either 100 mg/10 mL or 500 mg/50 mL single-dose vials. Each mL of solution contains 10 mg rituximab-pvvr, 0.056 mg of ...
Labeling.pfizer.comDA: 19 PA: 18 MOZ Rank: 43
Pfizer Co-Pay Portal
Please see full Prescribing Information for RUXIENCE, including BOXED WARNING and Medication Guide, or visit RUXIENCEhcp.com. Learn More. Please see full Prescribing Information for TRAZIMERA, including BOXED WARNING or visit TRAZIMERAhcp.com. Learn More. Prescribing Information. Learn More. Prescribing Information . Learn More. Affiliated …
Pfizercopay.comDA: 19 PA: 19 MOZ Rank: 27
HIGHLIGHTS OF PRESCRIBING INFORMATION up dose for …
During treatment with RUXIENCE and chemotherapy, obtain CBC with differential and platelet counts at weekly to monthly intervals and more frequently in patients who develop cytopenias [see Adverse Reactions (6.1)]. In patients with GPA or MPA, obtain CBC with differential and platelet counts at two to four month intervals during RUXIENCE ...
Accessdata.fda.govDA: 22 PA: 45 MOZ Rank: 75
FDA Approves Pfizer's Rituximab Biosimilar, Ruxience
July 23, 2019. Kelly Davio. The FDA has approved Pfizer’s rituximab biosimilar, Ruxience (rituximab-pvvr), referencing Rituxan. The biosimilar was approved to treat non-Hodgkin lymphoma, chronic lymphocytic leukemia, and granulomatosis with polyangiitis and microscopic polyangiitis. This article has been updated.
Centerforbiosimilars.comDA: 28 PA: 50 MOZ Rank: 93
Ruxience Intravenous: Uses, Side Effects, Interactions ... - WebMD
Ruxience 10 Mg/Ml Concentrate,Intravenous Immunomodulator, B-Lymphocyte Stimulator (Blys)-Spec Inhib - Uses, Side Effects, and More Generic Name(S): rituximab-pvvr View Free Coupon
Webmd.comDA: 13 PA: 49 MOZ Rank: 72
Ruxience 500 mg concentrate for solution for infusion
Ruxience 500 mg concentrate for solution for infusion. Each mL contains 10 mg of rituximab. Each 50 mL vial contains 500 mg of rituximab. Rituximab is a genetically engineered chimeric mouse/human monoclonal antibody representing a glycosylated immunoglobulin with human IgG1 constant regions and murine light-chain and heavy-chain variable region sequences.
Medicines.org.ukDA: 20 PA: 23 MOZ Rank: 54
Rituxan vs. Ruxience : MultipleSclerosis - reddit
1. level 1. · 10 mo. ago RRMS / rituximab, ldn / dx 08-2020. Can’t speak to Ruxience but I’m on Riximyo which is a less expensive biosimilar to rituxan (and just another branding of rituximab). It’s been good- smooth infusions and no noticeable …
Reddit.comDA: 14 PA: 50 MOZ Rank: 83
Frequently Asked Questions: Funding of Riximyo (rituximab) and …
Ruxience (rituximab) is listed on the ODB Formulary as a LU benefit for eligible ODB recipients for the treatment of RA, and for the management of patients with Granulomatosis with Polyangiitis [(GPA), also known as Wegener’s Granulomatosis (WG)] OR microscopic polyangiitis (MPA). Riximyo and Ruxience are funded for specific oncology indications through the Ministry’s New …
Health.gov.on.caDA: 20 PA: 50 MOZ Rank: 99
RUXIENCE (rituximab-pvvr) | Pfizer Medical Information - US
RUXIENCE Quick Finder Pfizer samples (for eligible HCPs) Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com .
Pfizermedicalinformation.comDA: 32 PA: 15 MOZ Rank: 61
FDA Approves Biosimilar Ruxience: Here's What You Need to Know
Ruxience is now the 22nd biosimilar product available to patients. Biosimilar approvals are contingent on the fact that they are highly similar to a reference product, or a product that has already been approved by the FDA. Biosimilars must also have no significant differences in safety or efficacy from the reference product.
Curetoday.comDA: 17 PA: 50 MOZ Rank: 98
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
glhomehealth.com | godaddy.com | 1 Year, 313 Days |